Biotech · Public company · Hayward, CA, US

Arcus Biosciences, Inc.

Ticker RCUS · SEC CIK 0001724521

Track this companyFree. Adds Arcus Biosciences, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials2523 recruiting or active

Pipeline programs27From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline27

CabozantinibPhase 3 · Metastatic Clear Cell Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
CasdatifanPhase 3 · Metastatic Clear Cell Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
GemcitabinePhase 3 · Metastatic Pancreatic Ductal AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Nab-paclitaxelPhase 3 · Metastatic Pancreatic Ductal AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
QuemliclustatPhase 3 · Metastatic Pancreatic Ductal AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
CarboplatinPhase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
DomvanalimabPhase 2 · Gastrointestinal Tract MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
DomvanalimabPhase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
FluorouracilPhase 2 · Gastrointestinal Tract MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
LeucovorinPhase 2 · Gastrointestinal Tract MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
OxaliplatinPhase 2 · Gastrointestinal Tract MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
PaclitaxelPhase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
PembrolizumabPhase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
PemetrexedPhase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
QuemliclustatPhase 2 · Gastrointestinal Tract MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
ZimberelimabPhase 2 · Gastrointestinal Tract MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
ZimberelimabPhase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
AB598Phase 1 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
CabozantinibPhase 1 · Clear Cell Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
casdatifanPhase 1 · Clear Cell Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
CasdatifanPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
FluorouracilPhase 1 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
IpilimumabPhase 1 · Clear Cell Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
LeucovorinPhase 1 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
OxaliplatinPhase 1 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
ZimberelimabPhase 1 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
ZimberelimabPhase 1 · Clear Cell Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials25

Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial CancerPHASE1_PHASE2 · RECRUITING · started Oct 20, 2026ClinicalTrials.gov NCT07667335 · fetched Nov 12, 2026
Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell CarcinomaPHASE1 · RECRUITING · started Sep 21, 2026ClinicalTrials.gov NCT07748988 · fetched Nov 12, 2026
Comparative PK Assessment Study of Casdatifan in Moderate Hepatically Impaired Participants Versus Matched Participants With Normal Hepatic FunctionPHASE1 · RECRUITING · started Aug 14, 2026ClinicalTrials.gov NCT07751250 · fetched Nov 12, 2026
Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCCPHASE2 · RECRUITING · started Mar 9, 2026ClinicalTrials.gov NCT07397611 · fetched Nov 12, 2026
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell CarcinomaPHASE3 · RECRUITING · started Sep 8, 2025ClinicalTrials.gov NCT07011719 · fetched Nov 12, 2026
Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01PHASE2 · ACTIVE_NOT_RECRUITING · started Feb 18, 2025ClinicalTrials.gov NCT06727565 · fetched Nov 12, 2026
Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal AdenocarcinomaPHASE3 · ACTIVE_NOT_RECRUITING · started Dec 13, 2024ClinicalTrials.gov NCT06608927 · fetched Nov 12, 2026
Combination Therapy in Patients With Localized Pancreatic Ductal AdenocarcinomaPHASE2 · RECRUITING · started May 10, 2024ClinicalTrials.gov NCT06048484 · fetched Nov 12, 2026
Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)PHASE2 · ACTIVE_NOT_RECRUITING · started Mar 8, 2024ClinicalTrials.gov NCT06048133 · fetched Nov 12, 2026
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced CancersPHASE1 · ACTIVE_NOT_RECRUITING · started Oct 13, 2023ClinicalTrials.gov NCT05891171 · fetched Nov 12, 2026
Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate CancerPHASE2 · RECRUITING · started Jul 1, 2023ClinicalTrials.gov NCT05915442 · fetched Nov 12, 2026
Domvanalimab and Zimberelimab in Advanced Liver CancersPHASE2 · ACTIVE_NOT_RECRUITING · started Jun 12, 2023ClinicalTrials.gov NCT05724563 · fetched Nov 12, 2026
Study of Novel Treatment Combinations in Patients With Lung CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Mar 16, 2023ClinicalTrials.gov NCT05633667 · fetched Nov 12, 2026
Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic AdenocarcinomaPHASE1_PHASE2 · RECRUITING · started Mar 7, 2023ClinicalTrials.gov NCT05688215 · fetched Nov 12, 2026
Study With Various Immunotherapy Treatments in Participants With Lung CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Feb 21, 2023ClinicalTrials.gov NCT05676931 · fetched Nov 12, 2026
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid TumorsPHASE1 · RECRUITING · started Oct 26, 2022ClinicalTrials.gov NCT05536141 · fetched Nov 12, 2026
Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung CancerPHASE3 · ACTIVE_NOT_RECRUITING · started Oct 12, 2022ClinicalTrials.gov NCT05502237 · fetched Nov 12, 2026
A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract MalignanciesPHASE2 · COMPLETED · started Jun 10, 2022ClinicalTrials.gov NCT05329766 · fetched Nov 12, 2026
A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.PHASE2 · RECRUITING · started Mar 31, 2022ClinicalTrials.gov NCT05024097 · fetched Nov 12, 2026
Zimberelimab (AB122) With TIGIT Inhibitor Domvanalimab (AB154) in PD-1 Relapsed/Refractory MelanomaPHASE2 · ACTIVE_NOT_RECRUITING · started Mar 16, 2022ClinicalTrials.gov NCT05130177 · fetched Nov 12, 2026
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLCPHASE3 · ACTIVE_NOT_RECRUITING · started Feb 18, 2022ClinicalTrials.gov NCT05211895 · fetched Nov 12, 2026
Safety and Efficacy of Zimberelimab (AB122) in Combination With Domvanalimab (AB154) and Etrumadenant (AB928) in Patients With Previously Treated Non-Small Cell Lung CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Aug 4, 2021ClinicalTrials.gov NCT04791839 · fetched Nov 12, 2026
AB154 Combined With AB122 for Recurrent GlioblastomaEARLY_PHASE1 · ACTIVE_NOT_RECRUITING · started Apr 21, 2021ClinicalTrials.gov NCT04656535 · fetched Nov 12, 2026
Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung CancerPHASE2 · COMPLETED · started Feb 8, 2021ClinicalTrials.gov NCT04736173 · fetched Nov 12, 2026
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical ProstatectomyPHASE2 · RECRUITING · started Oct 30, 2019ClinicalTrials.gov NCT03821246 · fetched Nov 12, 2026

SEC filings12

10-Q · 10-QSEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Oct 23, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Oct 21, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Oct 20, 2026 · fetched Nov 12, 2026
10-Q · 10-QSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Jun 12, 2026 · fetched Nov 12, 2026
10-Q · 10-QSEC EDGAR · filed May 5, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed May 5, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Apr 20, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Mar 23, 2026 · fetched Nov 12, 2026